545.0K XNAS Volume
XNAS 19 Mar, 2025 10:34 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 13 Mar 2025 | 600,000 | 5,674,916 | - | 13.5 | 8,100,000 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 6,349 | 115,880 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Mar 2025 | 6,349 | 170,869 | - | 1.1 | 6,857 | Common Stock |
| Glenn P. Sblendorio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 570,000 | 570,000 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Daphne Karydas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 0 | - | - | Stock Option | |
| Alexander M. Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Feb 2025 | 6,348 | 164,520 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 6,348 | 122,229 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 13 Jan 2025 | 18,333 | 877,608 | - | 9.1 | 166,082 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 13 Jan 2025 | 5,018 | 151,823 | - | 0.5 | 2,710 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 13 Jan 2025 | 6,349 | 158,172 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 5,018 | 0 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 6,349 | 128,577 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 9.09 per share. | 13 Jan 2025 | 10,657 | 226,197 | - | 9.1 | 96,901 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 9.63 per share. | 13 Jan 2025 | 100 | 226,097 | - | 9.6 | 963 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 5,017 | 5,018 | - | - | Stock Option | |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Dec 2024 | 5,017 | 146,008 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Nov 2024 | 5,017 | 140,991 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 5,026 | 134,926 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 5,017 | 10,035 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 11 Nov 2024 | 5,026 | 140,991 | - | 15.0 | 75,398 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Nov 2024 | 5,026 | 146,017 | - | 1.1 | 5,428 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 06 Nov 2024 | 25,482 | 135,974 | - | 15.0 | 383,066 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 06 Nov 2024 | 25,482 | 161,456 | - | 1.1 | 27,521 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 25,482 | 139,952 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.52 per share. | 11 Oct 2024 | 15,271 | 895,941 | - | 13.5 | 206,433 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Oct 2024 | 5,017 | 130,622 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 5,352 | 165,434 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 5,017 | 15,052 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Oct 2024 | 5,352 | 135,974 | - | 1.1 | 5,780 | Common Stock |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.57 per share. | 11 Oct 2024 | 10,757 | 236,854 | - | 13.6 | 146,004 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Sep 2024 | 5,018 | 119,256 | - | 0.5 | 2,710 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 6,349 | 170,786 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 5,018 | 20,069 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Sep 2024 | 6,349 | 125,605 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 6,348 | 177,135 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 5,017 | 25,087 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Aug 2024 | 6,348 | 114,238 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 12 Aug 2024 | 5,017 | 107,890 | - | 0.5 | 2,709 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 24 Jul 2024 | 550,000 | 8,644,579 | - | 13.1 | 7,177,500 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 525 | 183,483 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Jul 2024 | 525 | 102,873 | - | 15.0 | 7,876 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 16 Jul 2024 | 525 | 103,398 | - | 1.1 | 567 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 11 Jul 2024 | 15,746 | 911,212 | - | 13.3 | 210,075 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Jul 2024 | 6,349 | 102,873 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 6,349 | 184,008 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Jul 2024 | 5,017 | 96,524 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 5,017 | 30,104 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.14 per share. | 11 Jul 2024 | 10,757 | 247,611 | - | 13.1 | 141,394 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 17 Jun 2024 | 17,766 | 958,505 | - | 12.3 | 217,712 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.99 per share. | 17 Jun 2024 | 16,607 | 941,898 | - | 12.0 | 199,073 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.73 per share. | 17 Jun 2024 | 14,940 | 926,958 | - | 11.7 | 175,237 | Common Stock |
| Alexander M. Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 12 Jun 2024 | 16,607 | 1,032,461 | - | 12.8 | 212,013 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 12 Jun 2024 | 16,229 | 976,271 | - | 12.5 | 203,163 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.74 per share. | 12 Jun 2024 | 39,961 | 992,500 | - | 12.7 | 509,027 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 5,017 | 35,121 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Jun 2024 | 6,349 | 89,729 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Jun 2024 | 5,017 | 83,380 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 6,349 | 190,357 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 11 Jun 2024 | 96,815 | 255,462 | - | 12.9 | 1,252,718 | Common Stock |
| Glenn P. Sblendorio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Daphne Karydas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Olivier Litzka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 May 2024 | 22,000 | 0 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 13 May 2024 | 6,348 | 78,363 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 6,348 | 196,706 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 5,018 | 40,138 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 13 May 2024 | 5,018 | 72,015 | - | 0.5 | 2,710 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 09 May 2024 | 100 | 67,097 | - | 1.1 | 108 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 100 | 203,054 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 09 May 2024 | 100 | 66,997 | - | 15 | 1,500 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Apr 2024 | 5,017 | 60,648 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 6,349 | 203,154 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 5,017 | 45,156 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Apr 2024 | 6,349 | 66,997 | - | 1.1 | 6,857 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Mar 2024 | 6,348 | 55,631 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 6,348 | 209,503 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 5,017 | 50,173 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Mar 2024 | 5,017 | 49,283 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option | |
| Congleton Jon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 425,000 | 425,000 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 12 Feb 2024 | 6,349 | 44,266 | - | 1.1 | 6,857 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 12 Feb 2024 | 5,017 | 37,917 | - | 0.5 | 2,709 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 6,349 | 215,851 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 5,017 | 55,190 | - | - | Stock Option | |
| Akkaraju Srinivas | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 12 Feb 2024 | 555,555 | 5,074,916 | - | 13.5 | 7,499,993 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 11 Jan 2024 | 6,348 | 32,900 | - | 1.1 | 6,856 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 5,017 | 60,207 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 6,348 | 222,200 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Jan 2024 | 5,017 | 26,552 | - | 0.5 | 2,709 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 11 Dec 2023 | 5,018 | 20,069 | - | 0.5 | 2,710 | Common Stock |
| Rodman David | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 5,018 | 65,224 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.10 per share. | 17 Aug 2023 | 2,250 | 1,042,568 | - | 12.1 | 27,225 | Common Stock |
| Jon Congleton | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.89 per share. | 11 Aug 2023 | 2,000 | 1,040,318 | - | 12.9 | 25,780 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 80,909 | 85,293 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 74,625 | 166,202 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 10 Aug 2023 | 76,182 | 0 | - | 12.8 | 975,891 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 10 Aug 2023 | 76,182 | 76,182 | - | 1.1 | 82,277 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 10 Aug 2023 | 80,909 | 0 | - | 12.8 | 1,036,444 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 10 Aug 2023 | 80,909 | 80,909 | - | 0.5 | 43,691 | Common Stock |
| David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.16 per share. | 10 Aug 2023 | 74,625 | 0 | - | 13.2 | 982,065 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 10 Aug 2023 | 74,625 | 74,625 | - | 0.5 | 40,298 | Common Stock |
| David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 76,182 | 228,548 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 88,000 | 88,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 44,000 | 0 | - | - | Stock Option | |
| Takeshi Takahashi | Director | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 44,000 | 0 | - | - | Stock Option | |
| Olivier Litzka | Director | Other type of transaction at price $ 0.00 per share. | 27 Apr 2023 | 44,000 | 0 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 99,800 | 99,800 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Adam S. Levy | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 1,446,357 | 0 | - | - | Series B Preferred Stock | ||
| Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 3,581,861 | 3,581,861 | - | - | Common Stock | ||
| Srinivas Akkaraju | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 937,500 | 4,519,361 | - | 16 | 15,000,000 | Common Stock |
| Srinivas Akkaraju | Director, Ten Percent Owner | 14 Feb 2023 | 2,135,504 | 0 | - | - | Series A Preferred Stock | ||
| Adam S. Levy | CFO, Chief Bus. Off. and Secy. | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 6,250 | 350,811 | - | 16 | 100,000 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 2,142,751 | 0 | - | - | Series B Preferred Stock | ||
| Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 4,314,093 | 8,944,579 | - | - | Common Stock | ||
| Brian Taylor Slingsby | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 250,000 | 9,194,579 | - | 16 | 4,000,000 | Common Stock |
| Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 2,171,342 | 0 | - | - | Series A Preferred Stock | ||
| Srinivas Akkaraju | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Jon Congleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 250,046 | 250,046 | - | - | Stock Option | |
| David Rodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 104,186 | 104,186 | - | - | Stock Option | |
| Adam S. Levy | CFO, Chief Bus. Off. and Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 97,518 | 97,518 | - | - | Stock Option | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Common Stock | |
| Alexander G. Asam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Olivier Litzka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option | |
| Takeshi Takahashi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option |